Filing Flows › CTS (CTS) › Q3 2026 › vs Q3 2025
CTS (CTS) Q3 2026 vs Q3 2025 (year over year)
CTS's revenue rose $6.6M (+5%) from $143M in Q3 2025 to $150M in Q3 2026. Gross margin 42.2% against 38.7% (+3.5 pts).
CTS, Q3 2026: revenue $150M (+5% year over year), operating margin 17.1%, net earnings $17.8M, operating cash flow $43.5M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 42.2% | 38.7% | +3.5 pts |
| Operating margin | 17.1% | 14.6% | +2.4 pts |
| Net margin | 11.9% | 9.6% | +2.3 pts |
| Free cash flow margin | 27.5% | 16.9% | +10.6 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $150M | $143M | $6.6M | +5% |
| Gross profit | $63.2M | $55.3M | $7.8M | +14% |
| Cost of revenue | $86.4M | $87.6M | −$1.2M | -1% |
| Other income, net | $12.7M | −$1.2M | $13.9M | — |
| Operating profit | $25.5M | $20.9M | $4.6M | +22% |
| Operating expenses | $37.6M | $34.4M | $3.2M | +9% |
| Pre-tax earnings | $38.2M | $19.7M | $18.5M | +94% |
| Research & development | $6.3M | $6.9M | −$568K | -8% |
| SG&A | $30.8M | $27.2M | $3.6M | +13% |
| Other operating costs | $468K | $280K | $188K | +67% |
| Net earnings | $17.8M | $13.7M | $4.1M | +30% |
| Income tax | $20.5M | $6.0M | $14.4M | +239% |
| Depreciation & amortization | $8.7M | $8.8M | −$94K | -1% |
| Working capital & other | $17.0M | $6.5M | $10.5M | +162% |
| Operating cash flow | $43.5M | $29.0M | $14.5M | +50% |
| Free cash flow (OCF − capex) | $41.1M | $24.2M | $16.9M | +70% |
| Capital expenditures | $2.4M | $4.8M | −$2.4M | -50% |
Questions
How much did CTS's revenue grow year over year in Q3 2026?
CTS's revenue rose $6.6M (+5%) from $143M in Q3 2025 to $150M in Q3 2026. Gross margin 42.2% against 38.7% (+3.5 pts).